Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
0.697 %
$ 379 M
Market Cap
-1.4
P/E
PRME - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PRME - Prime Medicine, Inc.
655 K
LAST VALUE
-95.07%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR